RBC Sees 'Multi-Year Growth Runway' for Edwards Lifesciences (EW); PT Raised

December 5, 2024 8:10 AM EST Send to a Friend
RBC Capital analyst Shagun Singh raised the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $80.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login